Therapy News and Research

RSS

Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

Johnson & Johnson today announced sales of $16.0 billion for the third quarter of 2011, an increase of 6.8% as compared to the third quarter of 2010. Operational results increased 2.6% and the positive impact of currency was 4.2%. Domestic sales declined 3.7%.

18 Oct 2011

Study examines effectiveness of counseling approach for substance abuse among African-Americans

A new study is the first to examine the effectiveness of a widely used counseling approach to treating substance abuse among African-Americans. The study found that African-American women were more likely than men to continue a counseling approach to treating substance abuse, but their substance-abuse issues continued.

18 Oct 2011

National Centre for Bowel Research and Surgical Innovation to be set up in London

A national research centre for bowel disease is to be set up in London to bring the Cinderella area of medicine to the forefront of surgical innovation.

18 Oct 2011

Accera identifies genetic profile of AD patients with heightened response to Axona

Accera, Inc., a biotech company specializing in cognitive health, announced today that it has identified the genetic profile of Alzheimer’s disease (AD) patients who have a high probability of responding to Axona (AC-1202), a prescription medical food product available at pharmacies nationwide.

18 Oct 2011

St. Jude Medical commences use of renal denervation catheter and generator system

St. Jude Medical, Inc., a global medical device company, today announced the first use of the company's renal denervation catheter and generator system, as part of a feasibility study of the new technology. The technology was developed as a treatment for resistant hypertension (high blood pressure that is not well controlled by drug therapy).

18 Oct 2011

FDA approves Oxford BioMedica's UshStat IND to treat Usher syndrome type 1B

Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.

18 Oct 2011

Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiaries, Takeda Global Research & Development Center, Inc., and Takeda Global Research & Development Centre (Europe), Ltd., announced today the initiation of the Company's Phase 3 clinical trial program for TAK-875, an investigational therapy for type 2 diabetes.

18 Oct 2011

VEGF protein appears to prevent progression of spinocerebellar ataxia type 1

A protein that promotes the growth of neurons and blood vessels appears to stop the progression of a genetic disease that causes degeneration of the cerebellum, according to new preclinical Northwestern Medicine research published in Nature Medicine.

18 Oct 2011

Dendreon initiates enrollment in DN24-02 Phase 2 trial for HER2 positive cancer

Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.

18 Oct 2011

Study: Lung cancer patients with diabetes mellitus tend to live longer

Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer.

18 Oct 2011

NEP successfully inserts specific doses of anti-cancer gene into leukemia cells

For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.

18 Oct 2011

Brain tumour discovery offers drug treatment hope

Australian scientists have played a key role in the identification of a new biochemical mechanism that allows brain tumours to survive and grow, offering hope of new drug treatments for some of the most aggressive tumours.

17 Oct 2011

Love of money may damage marriage

A new study reveals that couple who think money and things before everything else might be worse off in their relationships than those who aren't as materialistic. The study was published in the Journal of Couple & Relationship Therapy.

16 Oct 2011

UEI tool could allow doctors to deliver efficient, timely treatment for Crohn's disease

It's difficult for doctors to tell whether a patient with Crohn's disease has intestinal fibrosis, which requires surgery, or inflammation, which can be treated with medicine. A new imaging method might make that task easier, according to a U-M-led study.

15 Oct 2011

New research on link between APOL1 gene variants and kidney disease in African Americans

Compared to European Americans, African Americans are four to five times more likely to develop kidney failure. Also, family members of African Americans with kidney failure have an increased risk of developing kidney failure, which suggests that genetics may play a role in this skewed risk between races.

15 Oct 2011

MRI scans may become useful tools for assessing cholesterol drugs

MRI scanning could become a powerful new tool for assessing how well cholesterol drugs are working, according to Loyola University Health System cardiologist Binh An P. Phan, MD.

15 Oct 2011

New onset tenderness after combo hormone therapy increases risk of breast cancer

Post-menopausal women who experience new onset breast tenderness after starting combination hormone therapy may have an increased risk of breast cancer compared to women who don't experience breast tenderness, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has shown.

15 Oct 2011

Overweight children more likely to develop asthma

Asthma is considered one of the main causes of school absenteeism and its prevalence has risen in the last decades. Overweight children have been shown to have double the frequency of asthma than that of non-obese children.

15 Oct 2011

Health groups urge Secretary of U.S. Army to sustain funding for military HIV research program

"Speaking out against a potential $16 million cut in the Army's base research and development budget for HIV, leaders of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter Thursday to the Secretary of the U.S. Army, John McHugh, making the case for sustaining the U.S. Military HIV Research Program (MHRP)," according to the Center for Global Health Policy's "Science Speaks" blog.

15 Oct 2011

ABI provides clinical update on company activities

Amarillo Biosciences, Inc. (ABI) today provided an update on company activities.

15 Oct 2011

Therapy News and Research

Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

Study examines effectiveness of counseling approach for substance abuse among African-Americans

National Centre for Bowel Research and Surgical Innovation to be set up in London

Accera identifies genetic profile of AD patients with heightened response to Axona

St. Jude Medical commences use of renal denervation catheter and generator system

FDA approves Oxford BioMedica's UshStat IND to treat Usher syndrome type 1B

Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes

VEGF protein appears to prevent progression of spinocerebellar ataxia type 1

Dendreon initiates enrollment in DN24-02 Phase 2 trial for HER2 positive cancer

Study: Lung cancer patients with diabetes mellitus tend to live longer

NEP successfully inserts specific doses of anti-cancer gene into leukemia cells

Brain tumour discovery offers drug treatment hope

Love of money may damage marriage

UEI tool could allow doctors to deliver efficient, timely treatment for Crohn's disease

New research on link between APOL1 gene variants and kidney disease in African Americans

MRI scans may become useful tools for assessing cholesterol drugs

New onset tenderness after combo hormone therapy increases risk of breast cancer

Overweight children more likely to develop asthma

Health groups urge Secretary of U.S. Army to sustain funding for military HIV research program

ABI provides clinical update on company activities

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News